Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite a modest
MDT Earnings: Highlights of Medtronic’s Q4 2022 results
Categories
Medical Devices
Medtronic PLC (MDT) Q4 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q4 2022 earnings call dated May. 26, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Boston Scientific Corp. (BSX) Q1 2022 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations Robert B. Ford -- Chairman
AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
Why Intuitive Surgical (ISRG) is a must-own stock after the recent dip
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities into overdrive,
Medtronic PLC (MDT) Q3 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q3 2022 earnings call dated Feb. 22, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head, Investor Relations Karen
Meihua’s IPO might set the stage for revival of Chinese listings in the US
Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks up momentum
Boston Scientific Corp (BSX) Q4 2021 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Edwards Lifesciences Corporation (EW) Q4 2021 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE: EW) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations & Treasurer
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Royal Philips NV (PHG) Q4 2021 Earnings Call Transcript
Royal Philips NV (AMS: PHG) Q4 2021 earnings call dated Jan. 24, 2022 Corporate Participants: Leandro Mazzoni -- Head of Investor Relations Frans van
IPO Alert: Here’s all you need to know about Bausch + Lomb’s market debut
After slowing down in the final weeks of 2021, IPO activity has picked up momentum despite the uncertain economic conditions. Eye care
Here are 2 top stock picks to enrich your portfolio in the new year
For businesses across the world, 2021 was a special year for many reasons -- a period of great uncertainty due to the
After strong Q3, Thermo Fisher (TMO) expects to end FY21 on a high note
The shares of Thermo Fisher Scientific Inc. (NYSE: TMO), a leading provider of analytical instruments and software, climbed to a record high
Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021
Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective medical procedures
Medtronic PLC (MDT) Q2 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Conmed Corp. (CNMD) Q3 2021 Earnings Call Transcript
Conmed Corp (NYSE: CNMD) Q3 2021 earnings call dated Oct. 27, 2021 Corporate Participants: Julie Hall -- Corporate Communications Manager & Executive Assistant to
Abbott Laboratories (ABT) Q3 2021 Earnings: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its third quarter financial results for the period ended September 30, 2021. GAAP net earnings for the
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions